Education
About Us
Working with TipRanks
Follow Us
Lee Tien-Li Insider Profile
4 Followers
Lee Tien-Li, Director at Scilex Holding Company, holds ― shares in Scilex Holding Company (Ticker: SCLX), holds 2.97M shares in Aardvark Therapeutics, Inc. (Ticker: AARD). Most recently, Lee Tien-Li ― shares of Scilex Holding Company on ― for an estimated value of ―.
Lee Tien-Li has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Lee Tien-Li holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Feb 19, 2025 - Today
Return:-32.00%
The most profitable trade made by Lee Tien-Li
Lee Tien-Li's Trading History
Scilex Holding Company
―
Director
―
―
Aardvark Therapeutics, Inc.
Feb 19, 2025
Chief Executive Officer, Director, Ten Percent Owner
Uninformative Buy
―
$30.09M
List of latest transactions for each holding click on a transaction to see Lee Tien-Li's performance on stock
You May Also Like
Lee Tien-Li insider profile FAQ
What is the percentage of profitable transactions made by Lee Tien-Li?
The percentage of profitable transactions made by Lee Tien-Li is ―.
What is the average return per transaction made by Lee Tien-Li?
The average return per transaction made by Lee Tien-Li is ―.
What stocks does Lee Tien-Li hold?
Lee Tien-Li holds: SCLX, AARD stocks.
What was Lee Tien-Li’s latest transaction?
Lee Tien-Li latest transaction was an Uninformative Buy of ―.
What was Lee Tien-Li's most profitable transaction?
Lee Tien-Li’s most profitable transaction was an Informative Buy of AARD stock on February 19, 2025. The return on the trade was -32.00%.
What is Lee Tien-Li's role in Scilex Holding Company?
Lee Tien-Li's role in Scilex Holding Company is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.